Page 83 - 71_02

VOL. 71 (2), 341-363, 2005 ANTITUMORALES MARINOS

(27) AVENDAÑO, C.; MENÉNDEZ, J. C. (1998): Recent Progress in the Synthesis of
(28) Antitumour Azaanthraquinones. Recent Res. Devel. in Organic Chem., 2, 69.
(29) BLANCO, M. M.; AVENDAÑO, C.; MENÉNDEZ, J. C. (2000): “(o-Trifluoroacetamido)-
(30) cinnamaldehyde Dimethylhydrazone, a Useful Azadiene in the Hetero Diels-
Alder Approach to the Pyrido[2,3,4-kl]acridine system”. Synlett, 689.
(31) FERNÁNDEZ PUENTES, J. L.; GARCÍA GRÁVALOS, D.; AVENDAÑO, C.; BLANCO, M. M.;
(32) MENÉNDEZ, J. C. Cytotoxic Compounds: Derivatives of the Pyrido[2,3,4-
(33) kl]acridine Ring System. US Patent 6,656,948 B2 (2-Diciembre-2003).
PÉREZ, J. M.; LÓPEZ-ALVARADO, P.; PASCUAL-ALFONSO, E.; AVENDAÑO, C.; MENÉNDEZ,
(34) J. C. (2000): Concise Preparation of 1,8-Diazaanthracene-2,7,9,10-tetraones.
(35) Two Alternative Syntheses of the Natural Antifolate Diazaquinomycin A.
(36) Tetrahedron 56, 1561.
(37) VILLACAMPA, M.; PÉREZ, J. M.; AVENDAÑO, C.; MENÉNDEZ, J. C. (1994): Ultrasound
(38) Assisted Diels-Alder Reactions of 1-Azadienes with “Normal” Electronic De-
(39) mand. Tetrahedron, 50, 10047.
(40) AOKI, S.; WEI, H.; MATSUI, K.; RACHMAT, R.; KOBAYASHI, M. (2003): Pyridoacri-
(41) dine Alkaloids Inducing Neuronal Differentiation in a Neuroblastoma Cell
(42) Line, from Marine Sponge Biemna fortis. Bioorg. Med. Chem., 9, 1139.
DE LA FUENTE, J. A.; MARTÍN, M. J.; BLANCO, M. M.; PASCUAL-ALFONSO, E.; AVEN-
DAÑO, C.; MENÉNDEZ, J. C. (2001): A Regioisomer of the Marine Alkaloid Me-
ridine Exhibits Selective in vitro Cytotoxicity for Solid Tumours. Bioorg.
Med. Chem., 9, 1807.
BLANCO, M. M.; AVENDAÑO, C.; MENÉNDEZ, J. C. (1999): Concise Synthesis of
Tetrahydro Derivatives of the Pyrido[2,3-b]acridine and Pyrido[3,2-b]acridine
Ring Systems. Tetrahedron, 55, 12637.
BLANCO, M. M.; AVENDAÑO, C.; MENÉNDEZ, J. C. (1999): Synthesis of 1,2,3,4-
Tetrahydroascididemin. Tetrahedron Lett., 40, 4097.
LUESCH, H.; MOORE, R. E.; PAUL, V. J.; MOOBERRY, S. L.; CORBETT, T. H. (2001):
J. Nat. Prod., 64, 907.
DE ROSA, S.; MITOVA, M.; TOMMONARO, G. (2003): Marine Bacteria Associated
with Sponge as Source of Cyclic Peptides. Biomol. Eng., 20, 311.
FENICAL, W.; SETHNA, K. M.; LLOYD, G. K. (2002): Marine Microorganisms as
a Developing Resource for Drug Discovery. Pharmaceutical News, 9, 489.
USUI, T.; KONDOH, M.; CUI, C.; MAYUMI, T.; OSADA, H. (1998): Tryprostatin A, a
Specific and Novel Inhibitor of Microtubule Assembly. Biochem. J., 333, 543.
WOEHLECKE, H.; OSADA, H.; HERRMANN, A.; LAGE, H. (2003): Reversal of breast
cancer resistance protein-mediated drug resistance by tryprostatin A. Int. J.
Cancer, 107, 721.
CABALLERO, E.; AVENDAÑO, C.; MENÉNDEZ, J. C. (2003): Brief Total Synthesis of
the Cell Cycle Inhibitor Tryprostatin B and Related Preparation of its Alanine
Analog. J. Org. Chem., 68, 6944.
PROKSCH, P.; EDRADA-EBEL, R. A.; EBEL, R. (2003): Drugs from the Sea? Oppor-
tunities and Obstacles. Mar. Drugs, 1, 5.

363